Endocrinology Vol. 141, No. 12 4449-4456
Copyright © 2000 by The Endocrine Society
Requirement for Follicle-Stimulating Hormone Action in the Formation of Primordial Follicles during Perinatal Ovarian Development in the Hamster1
Shyamal K. Roy and
Laura Albee
Leland J. and Dorothy L. Olson Center for Womens Health,
Departments of Obstetrics and Gynecology (S.K.R., L.A.), and
Physiology and Biophysics (S.K.R.), University of Nebraska Medical
Center, Omaha, Nebraska 68198-4515
Address all correspondence and requests for reprints to: Shyamal K. Roy, BH 3040, Departments of Ob/Gyn and Physiology and Biophysics, University of Nebraska Medical Center, 984515 Nebraska Medical Center, Omaha, Nebraska 68198-4515. E-mail: skroy{at}unmc.edu
 |
Abstract
|
|---|
Whereas FSH action is critical for the growth of preantral follicles,
its role in the development of primordial follicles is controversial.
The objective of the present study was to evaluate whether perinatal
(fetal through early postnatal) FSH action is needed for the formation
of primordial follicles, which first appear in the hamster ovary on the
7th to 8th day of postnatal life. A single dose of FSH-specific
polyclonal antibody was injected into pregnant hamsters on the 12th,
13th, or 14th day of gestation and into newborn hamsters. Some of the
antibody-exposed postnatal hamsters were injected with a single dose of
equine CG (eCG) to check the reversibility of the antibody action.
Ovaries were collected on D8pn or D12pn, and the percentage of
primordial, primary, and secondary follicles was quantitated
morphometrically. Ovaries of 8-day-old hamsters that were born to
mothers treated with a single sc dose of the anti-FSH-antibody on day
12 of gestation had significantly reduced numbers of primordial
follicles, compared with those treated with preimmune serum or saline
(2.4% vs. 25%); however, the antibody inhibition was
nearly completely reversed (
18%) by a single injection of eCG on
the first day of life. Delaying antibody treatment during late
gestation caused a time-dependent block in granulosa cell
differentiation, with a consequent proportional increase in the
percentage of primordial follicles. This indicates that FSH-induction
of primordial follicle development begins at a critical time of ovarian
development. On the other hand, shortening the postnatal duration of
eCG exposure reduced the degree of reversal, suggesting that prolonged
perinatal FSH action is essential for developing the full gamut of
primordial follicles. These results provide the first direct evidence
that FSH action during fetal ovarian development is critical for the
onset of primordial follicle formation.
 |
Introduction
|
|---|
THE ONSET OF differentiation of ovarian
somatic cells into granulosa cells, forming the first cohort of
primordial follicles, heralds the beginning of folliculogenesis in the
mammalian ovary. Follicular development in the ovary depends critically
on the action of FSH, the primary gonadotropin for folliculogenesis
(1). FSH action in the ovary is restricted to granulosa
cells, regardless of the state of ovarian development (2, 3). FSH functions by interacting with its cognate G
protein-coupled glycoprotein receptor, which resides in the cell
membrane (3). Factors regulating the formation of
primordial follicles remain an enigma, because it requires the active
participation of the oocyte and somatic cells, each of which has its
share of autocrine/paracrine factors (4). Whereas TGF-ß2
isoform has been detected in differentiating somatic cells in the
perinatal hamster ovary during primordial and primary follicle
formation (5), neuropeptide Y and cAMP have been suggested
to play a major role in FSH receptor induction in the neonatal rat
ovary (6). Despite the presence of an appreciable amount
of FSH in the serum of perinatal rats (7), mice
(8), and hamsters (5, 9), it is unclear
whether, during perinatal ovarian morphogenesis, FSH plays any role in
the onset of primordial follicle development. Recent studies have shown
that an inactivating mutation of either FSH-ß-subunit gene
(10) or FSH-receptor gene (11) results in
cessation of follicular development beyond preantral stages in the
homozygous mouse. However, a naturally occurring inactivating mutation
in human FSH receptors results in significant reduction in FSH
signaling, coinciding with hypoplastic ovaries containing few follicles
(12, 13, 14). Although, primordial follicles have been located
in the ovaries of women with FSH-receptor mutation
(12, 13, 14), whether their number is comparable with fertile
women remains unclear. Aittomaki et al. (13)
have suggested that ovaries with FSH-receptor mutation may not be
totally resistant to large amounts of FSH, which may induce some
follicular development, particularly at the earlier stages, but normal
folliculogenesis never occurs. At present, data based on genetic
manipulation is virtually limited to the mouse. FSH stimulates in
vitro growth of hamster primary and secondary follicles
(15, 16, 17, 18). The objective of the present study was to
determine whether perinatal FSH plays any role in the differentiation
of somatic cells into early granulosa cells at the onset of hamster
primordial follicle development. In contrast to rats or mice, ovaries
of newborn hamsters contain oocytes in the 1st meiotic prophase and
scattered undifferentiated somatic cells; morphologically distinct
primordial follicles are not present until 78 days postnatal
(D7pnD8pn) (5, 9, 19). Therefore, the perinatal hamster
ovary is an ideal model to address the inducible role of FSH in
primordial folliculogenesis.
 |
Materials and Methods
|
|---|
Adult golden hamsters with three consecutive estrous cycles were
housed under a 14-h light, 10-h dark cycle, in climate-controlled
quarters, according to United States Department of Agriculture
and Institutional Animal Care and Use Committee guidelines.
Moreover, the use of hamsters in this study was approved by the
Institutional Animal Care and Use Committee.
Generation and determination of specificity and efficacy of
polyclonal anti-FSH antibody
An anti-FSH antibody was raised in New Zealand white rabbits
using ovine FSH-20 with 5% and 2% LH and TSH contamination,
respectively (20). Blood was collected, before antigen
injection, for preimmune serum preparation. After a satisfactory titer
was reached, the specificity of the antiserum was verified, first by an
enzyme-linked immunosorbent assay using ovine-FSH-20 and
ovine-LH-25, and then by Western immunoblotting and chemiluminescence
(21) using 1 µg each of ovine-FSH-20, ovine-LH-25, ovine
PRL-19, and equine CG (eCG).
To verify the ability of the antibody to neutralize FSH action in
vivo, cyclic hamsters were injected sc with 200 µl of the
anti-FSH-antiserum, on proestrus, at 1600 h, after the
periovulatory LH surge but before the second FSH surge at 2200 h
(20); the latter induces preantral follicle growth
(15) and recruitment for ovulation (for review, see Ref.
1). Animals were checked the next morning for the estrous vaginal
discharge and again on estrus of the next cycle; ovaries were collected
and processed for morphological evaluation of follicle development.
Because pure hamster FSH does not exist, the cross-reactivity of the
FSH antiserum with hamster FSH was assessed by 1) competition assay;
and 2) Western immunoblotting of hamster pituitary lysate. For the
former protocol, [125I]-ovine FSH was incubated
at 4 C with an optimal dilution of the antiserum in the presence of
0.1, 0.5, 1, 10, 100, and 1000 ng ovine-FSH or LH, 10, 20, 40,
80, and 100 µl of serum from proestrous (day 4: 0900 h)
or long-term (10 days) hypophysectomized hamsters for 20 h. The
antibody-[125I]-FSH complex was precipitated
with goat-antirabbit-IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) and counted in a Packard (Packard
Instrument Co., Meriden, CT) auto- gamma counter. The
results were expressed as percentage binding against the amounts of FSH
or volume of serum. For Western immunoblotting of hamster pituitary
FSH, fresh pituitary glands were obtained from proestrous (D4:
0900 h) hamsters and were homogenized in ice-cold 1x RIPA buffer
[PBS (pH 7.4), 0.1% SDS, 1% NP-40, and 0.5% deoxycholate]
containing a protease inhibitor cocktail (Sigma, St.
Louis, MO). After 30 min on ice, the mixture was centrifuged for 20 min
at 12,000 rpm in a refrigerated IEC microfuge, the protein content of
the supernatant was determined by the BCA protein assay kit
(Pierce Chemical Co., Rockford, IL), and 40 µg of
hamster pituitary protein was electrophoresed under a reducing
condition, transferred to a nitrocellulose membrane, and probed with
the FSH-antiserum, as described previously (21). Positive
controls were 0.25 and 0.5 µg of ovine-FSH-20.
Determination of the optimal window of FSH action during primordial
folliculogenesis
Hamsters were mated on proestrous evening, and the presence of
sperm in the vagina next morning was considered as day 1 of gestation
(1DG). Pregnant hamsters were injected sc with 200 µl anti-FSH-serum
either on 12DG, 13DG, or 14DG; or pups were injected sc with 20 µl of
the antiserum on D1pn. Some animals received preimmune serum or saline
as controls. On D8pn, pups were anesthetized with nembutal, blood was
collected for FSH RIA, and ovaries were saved for morphometric
quantitation of primordial and primary follicle development.
Based on the results, in the next experiment, the antiserum was
injected into pregnant hamsters on 10DG. Because ovarian structures
consisting of germ cells and somatic cells are present by day 12 of
fetal life, the objective was to deprive somatic cells of any FSH
action during ovary formation so that primordial follicle formation
could be stopped completely. Ovaries were collected on D8pn, and
follicle development was quantitated morphometrically.
Determination of the presence of functional FSH receptor in fetal
hamster ovaries
Because [125I]-FSH autoradiography is
inconclusive for fetal ovaries and RRA is often not feasible because of
limited ovarian materials, production of cAMP, in response to FSH
in vitro, was assessed, following (with modification) a
protocol described by Sokka and Huhtaniemi (22). Ovaries
were collected from 13-day-old fetal hamsters and were cultured in 0.5
ml DMEM, as described previously (23), in the presence of
0.5 mM methylisobutylxanthine (MIX,
Calbiochem, San Diego, CA) and in the presence or absence
of 50 ng/ml ovine-FSH-19 (NIH) or 50 µM
forskolin (Calbiochem, San Diego, CA) for 24 h. After
termination, the medium was placed in a boiling water bath for 5 min,
clarified by centrifugation, and stored at -80 C for cAMP RIA.
eCG reversal of the antibody inhibition of primordial follicle
development
To determine whether the effect of the antiserum was
attributable to the inactivation of endogenous FSH or antibody-mediated
toxicity, pregnant hamsters received 200 µl antiserum on 12DG, and
pups received an sc injection of 20 IU eCG (Sigma) or
saline on D1pn; ovaries were collected on D8pn for follicular
morphometry. The rationale for using eCG was 1) its longer half-life;
2) no cross-reactivity with the anti-FSH-antiserum; and 3) binding to
the FSH receptor and induction of FSH-like activity in the hamster
(24).
To determine the time-course of eCG rescue of primordial follicle
formation, pregnant females were injected with 200 µl of the
anti-FSH-antiserum on 12DG, and pups received 20 IU eCG either on D1,
D4, or D6pn, with ovaries retrieved on D8pn.
Reversibility of the antiserum inhibition by endogenous FSH
Whether inactivation of FSH during pregnancy delays primordial
follicle development or makes the ovary refractory to subsequent FSH
signaling was determined by injecting pregnant hamsters with 200 µl
of the antiserum sc on 12DG or 13DG and ovaries collected on D12pn, at
a time when ovaries of untreated hamsters contain primordial through
secondary follicles with 4 layers of granulosa cells
(5).
Morphometric quantitation of primordial, primary, and secondary
follicle development
The percentage of follicles in different stages of development
was assessed from 2-µm-thick hematoxylin and eosin-stained plastic
sections, under 650x magnification, using the Image Pro Plus image
analysis software (Media Cybernetics, Silver Spring, MD).
Because primordial oocytes (i.e. oocytes in clusters and
without any somatic cell partners) dominate the ovaries of 8-day-old
hamsters (5, 19), the total number of oocytes with
nucleolus, regardless of their follicular association, was counted in a
given optical field. Next, the number of follicles, at various stages,
corresponding to those oocytes was determined. The fields were chosen
at random from the entire ovary, and 250 or more oocytes for each ovary
were counted. The proportion of follicles in an ovary was then
expressed as percentage of oocytes. An oocyte surrounded by the
cytoplasmic processes of at least one flattened parenchymal cell was
considered a primordial follicle, whereas a primary follicle was
defined as one surrounded by a complete layer of parenchymal cells, of
which the majority were cuboidal. Primordial follicles were identified
by a double-blind screening of coded slides, and the code was revealed
after completion of follicle counting.
Determination of serum levels of FSH and rabbit IgG
Sera from anti-FSH-serum-exposed animals were treated overnight
with protein A-agarose with a binding capacity of
19 mg IgG/ml to
remove any trace of the antibody and were used for FSH RIA using
[125I]-rat FSH, rat FSH standards, and antirat
FSH serum (NIH, Ref. 25).
Whether the antibody entered fetal blood was evaluated by injecting 200
µl anti-FSH serum into pregnant females, on 12DG, and the presence of
rabbit IgG in the serum of 1-day-old hamsters was detected by Western
immunoblotting (21). The stability of FSH-antiserum in the
plasma of postnatal hamsters was evaluated by immunodetection of rabbit
IgG in the sera of 8-day-old pups that received the antiserum either on
12DG or D1pn.
Determination of cAMP
cAMP was determined by using an RIA kit (Biomedical Research Instruments, Inc., Stoughton, MA) with a sensitivity of
0.05 pmol cAMP after acetylation. The data were presented as pmol cAMP
per ml medium per 24 h.
Data analysis
Morphometric evaluation of folliculogenesis was done on at least
3 ovaries, which were collected from 3 different pups born to different
mothers. Moreover, 250 or more oocytes from each ovary were counted to
determine the percentage of follicles at each size class. Follicles
were classified (26) as follows: stage 0, primordial
follicles with 1 or more flattened parenchymal cells; stage 1, primary
follicles with unlaminar granulosa cells, of which the majority were
cuboidal; stage 2, secondary follicles with 2 layers of granulosa
cells; stage 3, secondary follicles with 3 layers of granulosa cells;
and stage 4, secondary follicles with 4 layers of granulosa cells. All
data were analyzed by 2-way ANOVA and Scheffés test with
5% level of significance.
 |
Results
|
|---|
The polyclonal FSH antiserum detected a 40-kDa and a 29-kDa
protein in ovine FSH preparation (Fig. 1
), under a nonreducing condition, and
cross-reacted with an approximately 23-kDa protein in ovine FSH
preparation and in hamster pituitary lysate under a reducing condition
(Fig. 2
]) The electrophoretic pattern of
FSH corresponded well with that provided by the NIH. Moreover,
[125I]-ovine FSH binding to the antiserum was
inhibited by proestrous hamster serum but not by the serum from
long-term hypophysectomized hamsters or LH (Fig. 3
). The antiserum also completely blocked
antral follicle development in adult cyclic hamsters when administered
before the second FSH peak (Fig. 4
, A
and B).

View larger version (99K):
[in this window]
[in a new window]
|
Figure 1. Western blot-chemiluminescence verification of the
specificity of the anti-FSH-antibody. The specificity of the antibody
was tested using 1 µg each of o-FSH-20, o-LH-25, o-Prl, and eCG under
nonreducing conditions. The antibody cross-reacted only with FSH (40
kDa). The 29-kDa protein might represent a nonglycosylated form.
Interestingly, the antibody did not even detect any -subunit of LH.
|
|

View larger version (55K):
[in this window]
[in a new window]
|
Figure 2. Chemiluminescence analysis of the cross-reactivity
of the FSH antiserum with ovine FSH and hamster pituitary lysate under
reducing conditions. The antiserum detected a 23-kDa protein in the
hamster pituitary lysate corresponding to reduced-ovine FSH subunits.
Lanes 1 and 2, 0.25 and 0.5 µg ovine FSH-20, respectively; lane 3,
pituitary lysate of proestrous hamsters.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Figure 3. Displacement of [125I]-ovine FSH
binding to the FSH antiserum by proestrous hamster serum. The binding
of [125I]-ovine FSH to the antiserum was challenged with
increasing dosages of ovine-FSH, LH, and proestrous hamster
serum after the preovulatory gonadotropin surge (D4: 1600 h) or
serum from 10-day hypophysectomized female hamsters. Note that
proestrous hamster serum competed with [125I]-FSH for the
antiserum binding; however, LH and hypophysectomized hamster serum were
without effect, indicating that FSH antiserum cross-reacts with hamster
FSH. Hx, Hypophysectomy.
|
|

View larger version (158K):
[in this window]
[in a new window]
|
Figure 4. Photomicrographs of hamster ovaries at estrous
(D1: 0900 h) after an sc injection of (A) preimmune rabbit serum
or (B) anti-FSH-serum at proestrous (D4: 1600 h) of the previous
estrous cycle. The occurrence of normal cyclicity and ovulation in
serum-treated animals was evident by the presence of distinct corpora
lutea (CL), nonovulated antral follicles (UF), and preantral follicles
at stages 4 (S4), 5 (S5), and 6 (S6); however, no antral follicle or CL
was present in the antibody-treated hamsters. PGs, Pyknotic granulosa
cells; APF, atretic preantral follicle; aS5 and aS6, atretic S5 and S6,
respectively; magnification, x50.
|
|
Antiserum inhibition of primordial follicle formation
That FSH-antiserum entered the fetal circulation was evident by
the presence of rabbit IgG in15-day-old fetal hamster serum (Fig. 5
); however, only a trace amount of
rabbit IgG was present by D5pn when the antiserum was injected on 12DG
(data not shown). The antiserum did not interfere with the gestation
period, delivery time, placental weight, litter size, or litter weight.
Moreover, the pups showed normal phenotype, milk intake, and postpartum
weight gain, indicating that antiserum did not induce any adverse
change in the phenotype that could be construed as a potential cause of
retarded ovary development. No significant difference in the ovarian
weight was noted between the control and antiserum-exposed pups by day
D8pn (data not shown).

View larger version (64K):
[in this window]
[in a new window]
|
Figure 5. Chemiluminescence detection of rabbit IgG in
1-day-old hamster serum after an sc injection of FSH antiserum to
pregnant females on 12DG. The presence of rabbit IgG in the hamster
serum indicates that a considerable amount of FSH-antiserum enters the
fetal circulation when injected into the mother. The blot was probed
with a goat-antirabbit-IgG, which was preabsorbed with rat, mouse,
hamster, bovine, and human IgG to further increase the specificity.
Further, no signal was obtained when untreated hamster serum was probed
with the antibody (lane 3). Lane 1, 2 µl serum from 1-day-old
hamsters exposed to FSH-antiserum in utero; lane 2, 0.1
µl anti-FSH serum (rabbit serum); lane 3, 5 µl serum from untreated
1-day-old hamsters.
|
|
Eight-day-old ovaries from pups exposed to preimmune serum or saline on
12DG contained 24.8% primordial and 1.2% early primary follicles
(Figs. 6A
and 7
), which was similar to untreated
controls. However, antiserum exposure on 12DG dramatically reduced the
proportion of primordial follicles to 2.4% and completely blocked
primary follicle formation (Figs. 6B
and 7
). No further reduction in
the proportion of primordial follicles was noted when the antiserum was
injected on 10DG (data not shown). A gradual increase in primordial
follicle formation was noted when the antiserum treatment was delayed
to 13DG or 14DG (Fig. 7
), but the values were still significantly lower
than controls. No further improvement was noted when the antiserum was
injected on D1pn. However, a small percentage of primary follicles
developed (Fig. 7
), suggesting that FSH-dependent morphogenesis of
primordial follicles continues after birth, but the onset of FSH
signaling may occur around 12DG.

View larger version (121K):
[in this window]
[in a new window]
|
Figure 6. Photomicrographs of 8-day-old hamster ovaries
exposed to preimmune serum on 12DG (A), FSH-antiserum on 12DG (B), or
FSH-antiserum on D12G and eCG on d1pn (C). A, The presence of
primordial (S0) and primary (S1) follicles with distinct granulosa
cells (Gc) reflects normal ovarian development. The majority of the
oocytes (O) are in the dictyate stage. B, No distinct follicle
formation is evident. Clusters of O in the Pachytene stage and cords of
somatic cells (SC) indicate an arrest in primordial follicle
formation. C, The resumption of S0 and S1 follicle formation with
distinct Gc is evident after eCG administration on d1pn. A transitional
S1 follicle (tS1) is also visible. Magnification, x400.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Figure 7. Follicular development in 8-day-old hamsters
exposed to saline or the anti-FSH-serum during 12DG14DG or day 1 of
age. Note a dramatic reduction in primordial follicle and complete
absence of primary follicle formation after FSH-inactivation. Delaying
the antibody treatment allowed initial FSH action; and consequently,
more primordial follicles developed; however, inactivation of FSH
action, even after birth, significantly attenuated primordial follicle
formation. The proportion of follicles in an ovary was expressed as
percentage of oocytes because 8-day-old ovary contains primarily
oocytes and a small proportion of developing primordial and primary
follicles. Values with the same letters are significantly
(P < 0.05) different from each other.
|
|
Serum levels of FSH were 11 ± 1 ng/ml in 8-day-old control female
hamsters (Fig. 8
), thus corroborating
previous findings (5, 9). FSH levels were significantly
(P < 0.05) low in 8-day-old hamsters exposed to the
antiserum on 12DG; however, no FSH was detected when the antiserum was
injected on D1pn (Fig. 8
). FSH levels reached normal values (9 ±1
ng/ml) by D12pn after the antiserum exposure on 12DG, indicating a
gradual reversal of the availability of endogenous FSH (hence, its
action). Conversely, rabbit IgG was detectable in pups receiving the
antiserum postnatally.

View larger version (16K):
[in this window]
[in a new window]
|
Figure 8. Serum levels of FSH in 8-day- and 12-day-old
hamsters exposed to the FSH-antiserum either on 12DG or d1pn. Control
pups were exposed to preimmune serum. Values with the same letters are
significantly (P < 0.05) different from each
other.
|
|
In vitro production of cAMP by fetal hamster ovaries
Fetal hamster ovaries were capable of producing baseline levels of
cAMP in vitro in the presence of MIX (Fig. 9
). cAMP production increased more than
2-fold (P < 0.05) in response to FSH and more than
4-fold (P < 0.05) in response to forskolin (fig. 9
).

View larger version (26K):
[in this window]
[in a new window]
|
Figure 9. In vitro production of cAMP by
13-day-old fetal hamster ovaries. The ovaries were incubated with 0.5
mM methylisobutylxanthine, for 24 h, in the presence
or absence of FSH or forskolin. A significant increase in cAMP
production was noted in response to FSH or forskolin. Values with the
same letter are significantly different from each other.
|
|
Reversal of the antiserum inhibition of primordial folliculogenesis
by eCG or endogenous FSH
Administration of eCG, on D1pn, to pups exposed to antiserum on
12DG not only reversed the formation of primordial follicles to nearly
control levels but also induced a small proportion of primary follicles
(Figs. 6C
and 10
). The efficacy of eCG,
however, declined significantly as the treatment was delayed by 4 or 6
days (Fig. 10
), suggesting that primordial folliculogenesis is a
relatively long FSH-dependent process.

View larger version (17K):
[in this window]
[in a new window]
|
Figure 10. eCG (20 IU) reversal of the antiserum inhibition
of follicle development in 8-day-old hamsters that were exposed to the
antiserum on 12DG. Note that a single dose of eCG on D1pn significantly
(P < 0.0001) reversed primordial follicle
development by D8pn. Reduced induction of primordial follicle formation
was noted when eCG treatment was delayed. Values with the same letters
are significantly (P < 0.05) different from each
other.
|
|
The presence of increasing amounts of FSH by D8pn and D12pn in pups
exposed to the antiserum on 12DG correlated with increased development
of primordial and primary follicles by D12pn (Fig. 11
). In fact, the rate of
primordial-to-primary follicle transition seemed to have accelerated,
because there was no difference in the percentage of primary follicles
between the control and antiserum-exposed pups despite a significantly
lower percentage of primordial follicle development (Fig. 11
). However,
the percentage of stages 2 and 3 follicles (2 and 3 layers of granulosa
cells, respectively) was significantly lower than in controls, and
stage 4 follicles were completely absent (Fig. 11
). This indicated that
antiserum did not affect FSH receptors, given that eCG was able to
function. Therefore, when clearance and degradation adequately reduced
the serum antibody titer around D8pn (only a trace amount of rabbit IgG
was present by D5pn), functional FSH levels began to increase,
resulting in a compensatory induction of primordial follicles by D12pn
and the formation of primary follicles. The delay in folliculogenesis
beyond the primordial stage was more pronounced when the antiserum was
administered on 13DG (Fig. 11
).

View larger version (24K):
[in this window]
[in a new window]
|
Figure 11. Endogenous FSH reversal of the antiserum effect
in 12-day-old hamsters exposed to the antiserum on 12DG or 13DG. Stages
24 were secondary follicles with 24 layers of granulosa cells,
respectively. Values with the same letters are significantly
(P < 0.05) different from each other.
|
|
 |
Discussion
|
|---|
These results provide the first direct evidence that FSH
is essential for somatic cell differentiation into early granulosa
cells during the onset of primordial follicle development, at least in
the hamster. The results also indicate that the initiation of critical
FSH-mediated changes may occur between a window of 10DG and 12DG, but
the process of somatic cell differentiation into granulosa cells
continues during early postnatal life of the hamster. Moreover,
inactivating FSH during the critical period delays the onset of
primordial follicle formation (hence, subsequent folliculogenesis). FSH
regulation of granulosa cell function requires the presence of
functional FSH receptor and FSH ligand (27). Consistently
detectable amounts of FSH are present in neonatal mice
(28) and hamsters (5, 9). Moreover, FSH
receptor messenger RNA (mRNA) corresponding to exons 110 and
functional FSH receptors first appear at 5 days of age in the rat
(29) and mouse (30). In contrast, a
complementary DNA corresponding to full-length FSH receptor mRNA has
been detected in the hamster fetus as early as 13DG (S. K. Roy,
unpublished). That FSH mRNA is translated into functional FSH receptor
protein in the fetal hamster ovary is evident by the production of cAMP
in response to FSH in vitro. Moreover, ovarian response to
forskolin also suggests that active adenylate cyclase has developed in
ovarian somatic cells as early as 13 days of fetal life. Sokka and
Huhtaniemi (22) have shown that neonatal rat ovaries can
produce significantly more cAMP in response to 30 µg/ml human FSH
than untreated controls as early as 4 days of postnatal life, but
17-day-old fetal ovary can respond to cholera toxin in terms of cAMP
production. The difference in ovarian response to FSH between rats and
hamster can be attributed to species difference. Nevertheless, these
lines of evidence suggest that FSH modulation of follicular development
occurs at early perinatal period.
Lack of FSH (8) by an inactivating mutation of either
FSH-ß-subunit gene (10) or FSH-receptor gene
(11) blocks preantral-to-antral follicle transition in
homozygous mice, and genetic inactivation of growth differentiation
factor-9 results in follicular arrest beyond the late primary stage
(31). Because none of these studies has quantified
primordial or primary follicle development, the results do not fully
address the importance of FSH in primordial follicle development. It is
likely that silencing the FSH gene in the mouse may activate other
FSH-mediated compensatory mechanism(s), which induce follicular
morphogenesis. In fact, overexpression of cyclin D2, a granulosa
cell-specific mitotic cyclin (32), has been reported in
FSH receptor knockout mice (11). Nevertheless, women with
inactivating mutation in the extracellular domain of the FSH receptor
have streak gonads (12, 13, 14) with few follicles. Although
primordial follicles have been identified in ovaries with inactivating
FSH-receptor mutation, it is unclear whether their number matches
normal ovaries. Aittomaki et al. (12) have
further documented that the mutation responsible for the development of
hypoplastic ovaries in women occurs at the extracellular domain of the
receptor and leads to reduced hormone binding and cAMP production
capacity without affecting the affinity (12). These lines
of evidence clearly indicate that a low, but residual, FSH-receptor
activity may persist in the ovaries of women with FSH-receptor
mutation, which can provide adequate signal for primordial follicle
development. The development of a few primordial follicles in 8-day-old
hamsters, after gestational exposure to the FSH-antiserum, confirms
that low FSH activity may be adequate for the initiation of primordial
follicle formation, but a prolonged FSH action is needed for the
development of a full cohort of primordial follicles.
The inhibition of primordial follicle formation by the anti-FSH serum
given during the critical window of FSH action on the fetal ovary, and
its reversal by eCG, suggests that perinatal FSH plays an important
role in the onset of somatic cell differentiation into granulosa cells,
which is essential for the development of the very first cohort of
primordial follicles. Moreover, FSH action seems to begin long before
primordial follicles appear, i.e. by D7pnD8pn of postnatal
life. This notion is supported by the development of approximately
2.4% primordial follicles in pups exposed to the antiserum on 12DG. It
is likely that only a few somatic cells are capable of processing the
FSH signal by 12DG; and once committed, they differentiate into
granulosa cells to form primordial follicles despite a subsequent block
in FSH action. This is further evident by the progressive increase in
primordial follicle development when antiserum treatment is
delayed.
The failure to develop a full cohort of primordial follicles by D8pn,
even when the antiserum treatment was delayed until D1pn, suggests that
sustained FSH signaling is essential until all presumptive granulosa
cells are differentiated and become associated with the oocyte to
constitute the finite pool of primordial follicles. Interruption of FSH
action, at anytime during this period, blocks further cell
differentiation while cells that have already received FSH stimulus
undergo differentiation, resulting in a final low number of primordial
follicles. The presence of serum FSH in 8-day-old hamsters exposed to
the antiserum on 12DG correlates with the decline in serum antiserum
concentration and suggests that antiserum-induced inactivation of FSH
is a reversible process. The temporal eCG action in reversing the
antiserum inhibition supports this contention. Moreover, eCG reversal
also indicates that the antiserum inhibition is specifically caused by
inactivation of endogenous FSH and not a nonspecific antibody-mediated
toxicity. This is further evident from the failure of the preimmune
rabbit serum to block primordial follicle formation. Because
LH-receptors do not appear in the hamster ovary before 15 days of age
(33), eCG effect cannot be attributed to any inherent
LH-like activity.
It seems that FSH-mediated differentiation of somatic cells into
granulosa cells is a slow process, spanning through several days of the
perinatal period (i.e. late prenatal through early
postnatal) and can be halted at any time during this period without any
permanent adverse consequence. Therefore, no differentiation induction
may occur when FSH action is blocked on 10DG but will resume when FSH
is available; and consequently, some primordial follicles will be
formed by D8pn. On the other hand, if the initiation of FSH-mediated
signaling occurs by 12DG, as evident in the present study, some cells
will differentiate before the antibody, given on 12DG, completely
neutralizes serum FSH and will form some primordial follicles by D8pn.
This mechanism may explain why the development of primordial follicles
cannot be blocked completely, even when the antiserum is injected
before 12DG. The degree of initial differentiation (hence, the
percentage of primordial follicles developed) by D8pn will depend on
the timing of initiation of FSH inactivation.
A rapid induction of primordial follicles within 4 days after D8pn in
gestationally antiserum-exposed hamsters suggests the possibility that
1) FSH availability increases after D8pn; and 2) somatic cell
responsiveness to FSH heightens because of the increased presence of
FSH receptors. Serum FSH levels in postnatal hamsters start to increase
after D9pn (5, 9), and serum FSH levels are closer to the
untreated values by D12pn in hamsters exposed to the antiserum on 12DG.
If the antiserum inactivates FSH, a possible reduction in FSH-induced
receptor down-regulation is likely, which may subsequently accelerate
the process of differentiation. Because the presence of functional FSH
receptors is a prerequisite for FSH action, factors inducing FSH
receptors must work in conjunction with FSH for granulosa cell
differentiation. Mayerhofer et al. (6) have
suggested that cAMP inducers, such as vasoactive intestinal peptide,
may be responsible for FSH receptor induction in neonatal rat ovary.
Whether such a mechanism exists in the hamster needs further
evaluation; however, the production of cAMP in response to FSH in
vitro has been demonstrated in the present study.
 |
Acknowledgments
|
|---|
We thank the National Pituitary Program and Dr. A. F.
Parlow for generously providing FSH and the FSH RIA kit. We are
grateful to Dr. Gilbert S. Greenwald, University of Kansas Medical
Center, for his meticulous help in the preparation of the
manuscript.
 |
Footnotes
|
|---|
1 This work was supported by grants from National Institute of
Child Health and Human Development (HD-28165) and Olson Foundation of
Omaha. 
Received May 15, 2000.
 |
References
|
|---|
-
Greenwald GS, Roy SK 1994 Follicular
selection. In: Knobil E, Neill JD (eds) The Physiology of Reproduction.
Raven Press, New York, pp 629724
-
Simoni M, Gromoll J, Nieschlag E 1997 The
follicle-stimulating hormone receptor: biochemistry, molecular biology,
physiology, and pathophysiology. Endocr Rev 18:739773[Abstract/Free Full Text]
-
Richards JS1994 Hormonal control of gene
expression in the ovary. Endocr Rev 15:404417
-
Roy SK 1994 Regulation of ovarian follicular
development: a review of microscopic studies. Microsc Res Tech 27:8396[CrossRef][Medline]
-
Roy SK, Hughes J 1994 Ontogeny of granulosa cells
in the ovary: lineage specific expression of transforming growth
factor-ß2 and transforming growth factor-ß1. Biol Reprod 51:821830[Abstract]
-
Mayerhofer A, Disney GA, Costa ME, Owed SR 1997 A
role for neurotransmitters in early follicular development: induction
of functional follicle-stimulating hormone receptors in newly formed
follicles of the rat ovary. Endocrinology 138:33203329[Abstract/Free Full Text]
-
Uilenbroek JTHJ, Arendsen DWE, Welschen R 1976 Studies on the significance of the high levels of follicle-stimulating
hormone for follicular development in immature rats. Ann Biol
Anim Biochem Biophys 16:297305
-
Halpin DMG, Jones A, Fink G, Charlton HM 1986 Postnatal ovarian follicle development in hypogonadal (hpg) and normal
mice and associated changes in the hypothalamic pituitary axis. J
Reprod Fertil 77:287296[Abstract/Free Full Text]
-
Vomachka AJ, Greenwald GS 1979 The development of
gonadotropin and steroid hormone patterns in male and female from birth
to puberty. Endocrinology 105:960966[Abstract/Free Full Text]
-
Kumar TR, Wang Y, Lu N, Matzuk MM 1998 Genetic
rescue of follicle-stimulating hormone ß-deficient mice. Nat
Genet 15:201204
-
Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A,
LeMeur M, Sassone-Corsi M 1998 Impairing follicle-stimulating
hormone (FSH) signaling in vivo: targeted disruption of the
FSH receptor leads to aberrant gametogenesis and hormonal imbalance.
Proc Natl Acad Sci USA 95:1361213617[Abstract/Free Full Text]
-
Aittomaki K, Lucena JLD, Pakarinen P, Sistonen P,
Tapanainen J, Gromoll J, Kaskikari R, Sankila EM, Levaslaiho H, Engel
AR, Nieschlag E, Huhtaniemi L, Chapelle ADL 1995 Mutation in the
follicle-stimulating hormone receptor gene causes hereditary
hypergonadotropic ovarian failure. Cell 82:959968[CrossRef][Medline]
-
Aittomaki K, Herva R, Stenman UH, Juntunen K, Ylostalo
P, Hovatta O, Chapelle ADL 1996 Clinical features of primary
ovarian failure caused by a point mutation in the follicle-stimulating
hormone receptor gene. J Clin Endocrinol Metab 81:37223726[Abstract]
-
Tapanainen JS, Vaskivuo T, Aittomaki K, Huhtaniemi
IT 1998 Inactivating FSH receptor mutations and gonadal
dysfunction. Mol Cell Endocrinol 145:129135[CrossRef][Medline]
-
Roy SK, Greenwald GS 1986a Quantitative analysis of
in vitro incorporation of
[3H]thymidine into hamster follicles during the
estrous cycle. J Reprod Fertil 77:143152
-
Roy SK, Greenwald GS 1986b Effects of FSH, and LH
on incorporation of [3H]thymidine into
follicular DNA. J Reprod Fertil 78:201209
-
Roy SK, Greenwald GS 1989 Hormonal requirements for
the growth and differentiation of hamster preantral follicles in
long-term culture. J Reprod Fertil 87:103114[Abstract/Free Full Text]
-
Roy SK, Harris SG 1994 Antisense EGF
oligonucleotide inhibits follicle-stimulating hormone-induced in
vitro DNA and progesterone synthesis in hamster preantral
follicles. Mol Endocrinol 8:11751181[Abstract/Free Full Text]
-
Weakley BS 1967 Light and electron microscopy of
developing germ cells and follicle cells in the ovary of the golden
hamster: twenty-four hours before birth to eight days postpartum. J
Anat 101:435459[Medline]
-
Roy SK, Greenwald GS 1990 Immunohistochemical
localization of epidermal growth factor-like activity in the hamster
ovary with a polyclonal antibody. Endocrinology 126:13091317[Abstract/Free Full Text]
-
Roy SK, Kole AR 1995 Transforming growth factor-ß
receptor type II (TßRII) expression in the hamster ovary: cellular
site(s), biochemical properties and hormonal regulation. Endocrinology 136:46104620[Abstract]
-
Sokka T, Huhtaniemi I 1990 Ontogeny of gonadotropin
receptors and gonadotropin-stimulated cyclic AMP production in the
neonatal rat ovary. J Endocrinol 127:297303[Abstract/Free Full Text]
-
Yu N, Roy SK 1999 Development of primordial
and prenatal follicles from undifferentiated somatic cells and oocytes
in the hamster prenatal ovary in vitro: effect of insulin.
Biol Reprod 61:689712
-
Siegel HI, Bast JD, Greenwald GS 1976 The effects
of phenobarbital and gonadal steroids on periovulatory serum levels of
luteinizing hormone and follicle-stimulating hormone in the hamster.
Endocrinology 98:4855[Abstract/Free Full Text]
-
Greenwald GS 1974 Quantitative aspects of
follicular development in the untreated and PMS-treated cyclic hamster.
Anat Rec 178:139143[CrossRef][Medline]
-
Roy SK, Greenwald GS 1985 An enzymatic method for
dissociation of intact follicles from the hamster ovary: histological
and quantitative aspects. Biol Reprod 32:203215[Abstract]
-
Tapanainen JS, Vaskivuo T, Aittomaki K, Huhtaniemi
IT 1998 Inactivating FSH receptor mutations and gonadal
dysfunction. Mol Cell Endocrinol 145:129135
-
Stiff ME, Bronson FH, Stetson MH 1974 Plasma
gonadotropins in prenatal and prepubertal female mice: disorganization
of pubertal cycles in the absence of a male. Endocrinology 94:492496[Abstract/Free Full Text]
-
Sokka TA, Hamalainen TM, Huhtaniemi IT 1992 Functional LH receptor appears in the neonatal rat ovary after changes
in the alternate splicing pattern of the LH receptor mRNA. J
Physiol Pharmacol 43: 2131
-
OShaughnessy PJ, Marsh P, Dudley K 1994 Follicle-stimulating hormone receptor mRNA in the mouse ovary during
postnatal development in the normal mouse and in the adult hypogonadal
(hpg) mouse: structure of alternate transcripts. Mol Cell Endocrinol 101:197201[CrossRef][Medline]
-
Elvin JA, Yan C, Wang P, Nishimori K, Matzuk MM 1999 Molecular characterization of the follicle defects in the growth
differentiation factor 9-deficient ovary. Mol Endocrinol 13:10181034[Abstract/Free Full Text]
-
Robker RL, Richards JS 1998 Hormone-induced
proliferation and differentiation of granulosa cells: a coordinated
balance of the cell cycle regulators cyclin D2 and p27kip1.
Mol Endocrinol 12:924940[Abstract/Free Full Text]
-
Shaha C, Greenwald GS 1983 Development of
steroidogenic activity in the ovary of the prepubertal hamster. Biol
Reprod 28:12311242[CrossRef][Medline]
This article has been cited by other articles:

|
 |

|
 |
 
D. Adhikari and K. Liu
Molecular Mechanisms Underlying the Activation of Mammalian Primordial Follicles
Endocr. Rev.,
August 1, 2009;
30(5):
438 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wang and S. K. Roy
Expression of Bone Morphogenetic Protein Receptor (BMPR) during Perinatal Ovary Development and Primordial Follicle Formation in the Hamster: Possible Regulation by FSH
Endocrinology,
April 1, 2009;
150(4):
1886 - 1896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A McLaughlin and S. C McIver
Awakening the oocyte: controlling primordial follicle development
Reproduction,
January 1, 2009;
137(1):
1 - 11.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.L.H. Ireland, D. Scheetz, F. Jimenez-Krassel, A.P.N. Themmen, F. Ward, P. Lonergan, G.W. Smith, G.I. Perez, A.C.O. Evans, and J.J. Ireland
Antral Follicle Count Reliably Predicts Number of Morphologically Healthy Oocytes and Follicles in Ovaries of Young Adult Cattle
Biol Reprod,
December 1, 2008;
79(6):
1219 - 1225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wang, E. R. Prossnitz, and S. K. Roy
G Protein-Coupled Receptor 30 Expression Is Required for Estrogen Stimulation of Primordial Follicle Formation in the Hamster Ovary
Endocrinology,
September 1, 2008;
149(9):
4452 - 4461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Morimoto, Y. Oku, M. Sonoda, A. Haruki, K. Ito, S. Hashimoto, and A. Fukuda
High oxygen atmosphere improves human follicle development in organ cultures of ovarian cortical tissues in vitro
Hum. Reprod.,
December 1, 2007;
22(12):
3170 - 3177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wang and S. K. Roy
Development of Primordial Follicles in the Hamster: Role of Estradiol-17{beta}
Endocrinology,
April 1, 2007;
148(4):
1707 - 1716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wang and S. K. Roy
Expression of Growth Differentiation Factor 9 in the Oocytes Is Essential for the Development of Primordial Follicles in the Hamster Ovary
Endocrinology,
April 1, 2006;
147(4):
1725 - 1734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C M Allan, Y Wang, M Jimenez, B Marshan, J Spaliviero, P Illingworth, and D J Handelsman
Follicle-stimulating hormone increases primordial follicle reserve in mature female hypogonadal mice.
J. Endocrinol.,
March 1, 2006;
188(3):
549 - 557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Steckler, J. Wang, F. F. Bartol, S. K. Roy, and V. Padmanabhan
Fetal Programming: Prenatal Testosterone Treatment Causes Intrauterine Growth Retardation, Reduces Ovarian Reserve and Increases Ovarian Follicular Recruitment
Endocrinology,
July 1, 2005;
146(7):
3185 - 3193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Yang, J. Wang, Y. Shen, and S. K. Roy
Developmental Expression of Estrogen Receptor (ER) {alpha} and ER{beta} in the Hamster Ovary: Regulation by Follicle-Stimulating Hormone
Endocrinology,
December 1, 2004;
145(12):
5757 - 5766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-M. Zhang and S. K. Roy
Downregulation of Follicle-Stimulating Hormone (FSH)-Receptor Messenger RNA Levels in the Hamster Ovary: Effect of the Endogenous and Exogenous FSH
Biol Reprod,
June 1, 2004;
70(6):
1580 - 1588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang and S. K. Roy
Growth Differentiation Factor-9 and Stem Cell Factor Promote Primordial Follicle Formation in the Hamster: Modulation by Follicle-Stimulating Hormone
Biol Reprod,
March 1, 2004;
70(3):
577 - 585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Balla, N. Danilovich, Y. Yang, and M. R. Sairam
Dynamics of Ovarian Development in the FORKO Immature Mouse: Structural and Functional Implications for Ovarian Reserve
Biol Reprod,
October 1, 2003;
69(4):
1281 - 1293.
[Abstract]
[Full Text]
[PDF]
|
 |
|